Patent ID: 6544969
Filing Date: 2003-04-08
Classification: A61P,C07C,Y02P

Abstract:
A method of treating metabolic bone disease where it is desired to maintain or increase bone mass comprising administering to a patient with said disease an effective amount of a compound selected from the group consisting of19-nor-26,27-dihomo-20(S)-2&agr;-methyl-1&agr;,25-dihydroxyvitamin D3, 19-nor-26,27-dihomo-20(S)-2&bgr;-methyl-1&agr;,25-dihydroxyvitamin D3, 19-nor-26,27-dimethylene-20(S)-2&agr;-methyl-1&agr;,25-dihydroxyvitamin D3, and 19-nor-26,27-dimethylene-20(S)-2&bgr;-methyl-1&agr;,25-dihydroxyvitamin D3.